Skip to main content

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • For Subscribers
    • For Advertisers
    • Terms & Conditions of Use
    • Permissions
  • About Us
    • About JPET
    • Feedback
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • For Subscribers
    • For Advertisers
    • Terms & Conditions of Use
    • Permissions
  • About Us
    • About JPET
    • Feedback
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
Research ArticleMetabolism, Transport, and Pharmacogenomics

Cynomolgus Monkey as a Potential Model to Assess Drug Interactions Involving Hepatic Organic Anion Transporting Polypeptides (OATPs): In Vitro, In Vivo and In Vitro-to-In Vivo Extrapolation

Hong Shen, Zheng Yang, Gabe Mintier, Yong-Hae Han, Cliff Chen, Praveen Balimane, Mohammed Jemal, Weiping Zhao, Renjie Zhang, Sanjith Kallipatti, Sabariya Selvam, Sunil Sukrutharaj, Prasad Krishnamurthy, Punit Marathe and David A Rodrigues
Journal of Pharmacology and Experimental Therapeutics January 7, 2013, jpet.112.200691; DOI: https://doi.org/10.1124/jpet.112.200691
Hong Shen
Bristol-Myers Squibb;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zheng Yang
Bristol-Myers Squibb;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gabe Mintier
Bristol-Myers Squibb;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yong-Hae Han
Bristol-Myers Squibb;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cliff Chen
Bristol-Myers Squibb;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Praveen Balimane
Bristol-Myers Squibb;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mohammed Jemal
Bristol-Myers Squibb;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Weiping Zhao
Bristol-Myers Squibb;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Renjie Zhang
WuXi AppTec Co., Ltd;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sanjith Kallipatti
Bristol-Myers Squibb Biocon R&D Center
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sabariya Selvam
Bristol-Myers Squibb Biocon R&D Center
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sunil Sukrutharaj
Bristol-Myers Squibb Biocon R&D Center
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Prasad Krishnamurthy
Bristol-Myers Squibb Biocon R&D Center
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Punit Marathe
Bristol-Myers Squibb;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David A Rodrigues
Bristol-Myers Squibb;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF + SI
  • PDF
Loading

Abstract

Organic anion transporting polypeptides (OATP) 1B1, 1B3 and 2B1 can serve as the loci of drug-drug interactions (DDIs). Therefore, the cynomolgus monkey was evaluated as a potential model for studying OATP-mediated DDIs. Three cynomolgus monkey OATPs (cOATPs), with a high degree of amino acid sequence identity (91.9%, 93.5%, and 96.6% for OATP1B1, 1B3 and 2B1, respectively) to their human counterparts, were cloned, expressed and characterized. The cOATPs were stably transfected in human embryonic kidney cells and were functionally similar to the corresponding human OATPs (hOATPs), as evident from the similar uptake rate of typical substrates (estradiol-17β-D-glucuronide, cholecystokinin octapeptide and estrone-3-sulfate). Moreover, 6 known hOATP inhibitors exhibited similar IC50 values against cOATPs. To further evaluate the appropriateness of the cynomolgus monkey as a model, a known hOATP substrate (rosuvastatin, RSV)-inhibitor (rifampicin, RIF) pair was examined in vitro and the monkey-derived parameters (RSV Km and RIF IC50) were similar (within 3.5-fold) to those obtained with hOATPs and human primary hepatocytes. In vivo, the area under the plasma concentration-time curve of RSV (3 mg/kg, oral) 1 hour after a single RIF dose (15 mg/kg, oral) was increased 2.9-fold in cynomolgus monkeys, consistent with the value (3.0-fold) reported in humans. A number of in vitro-in vivo extrapolation approaches, considering the fraction of the pathways affected and free vs. total inhibitor concentrations, were explored also. It is concluded that the cynomolgus monkey has the potential to serve as a useful model for the assessment of OATP-mediated DDIs in a nonclinical setting.

  • drug metabolism
  • drug-drug interactions
  • pharmacokinetic / pharmacodynamic modeling
  • pharmacokinetics
  • transporters
  • Received September 27, 2012.
  • Revision received January 4, 2013.
  • Accepted January 4, 2013.
  • The American Society for Pharmacology and Experimental Therapeutics
Next
Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics: 365 (2)
Journal of Pharmacology and Experimental Therapeutics
Vol. 365, Issue 2
1 May 2018
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Cynomolgus Monkey as a Potential Model to Assess Drug Interactions Involving Hepatic Organic Anion Transporting Polypeptides (OATPs): In Vitro, In Vivo and In Vitro-to-In Vivo Extrapolation
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
Citation Tools
Research ArticleMetabolism, Transport, and Pharmacogenomics

Cynomolgus Monkey as a Potential Model to Assess Drug Interactions Involving Hepatic Organic Anion Transporting Polypeptides (OATPs): In Vitro, In Vivo and In Vitro-to-In Vivo Extrapolation

Hong Shen, Zheng Yang, Gabe Mintier, Yong-Hae Han, Cliff Chen, Praveen Balimane, Mohammed Jemal, Weiping Zhao, Renjie Zhang, Sanjith Kallipatti, Sabariya Selvam, Sunil Sukrutharaj, Prasad Krishnamurthy, Punit Marathe and David A Rodrigues
Journal of Pharmacology and Experimental Therapeutics January 7, 2013, jpet.112.200691; DOI: https://doi.org/10.1124/jpet.112.200691

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleMetabolism, Transport, and Pharmacogenomics

Cynomolgus Monkey as a Potential Model to Assess Drug Interactions Involving Hepatic Organic Anion Transporting Polypeptides (OATPs): In Vitro, In Vivo and In Vitro-to-In Vivo Extrapolation

Hong Shen, Zheng Yang, Gabe Mintier, Yong-Hae Han, Cliff Chen, Praveen Balimane, Mohammed Jemal, Weiping Zhao, Renjie Zhang, Sanjith Kallipatti, Sabariya Selvam, Sunil Sukrutharaj, Prasad Krishnamurthy, Punit Marathe and David A Rodrigues
Journal of Pharmacology and Experimental Therapeutics January 7, 2013, jpet.112.200691; DOI: https://doi.org/10.1124/jpet.112.200691
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF + SI
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Hepatobiliary disposition of atovaquone: A case of mechanistically unusual biliary clearance
  • In vitro – in vivo extrapolation of OATP1B-mediated drug-drug interactions in cynomolgus monkey
  • FXR Agonists Increase Bile Acid Efflux in Human Hepatocytes
Show more Metabolism, Transport, and Pharmacogenomics

Similar Articles

  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2018 by the American Society for Pharmacology and Experimental Therapeutics